Original Research
Published on 16 May 2025
A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
in Cancer Molecular Targets and Therapeutics
- 279 views
Original Research
Published on 16 May 2025
in Cancer Molecular Targets and Therapeutics
Correction
Accepted on 15 May 2025
in Cancer Molecular Targets and Therapeutics
Perspective
Published on 15 May 2025
in Cancer Molecular Targets and Therapeutics
Review
Published on 15 May 2025
in Cancer Molecular Targets and Therapeutics
Review
Published on 14 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 13 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 13 May 2025
in Cancer Molecular Targets and Therapeutics
Review
Published on 13 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 12 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 12 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 09 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 09 May 2025
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 09 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 09 May 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 08 May 2025
in Cancer Molecular Targets and Therapeutics
Review
Accepted on 08 May 2025
in Cancer Molecular Targets and Therapeutics